Skip to main content
SpringerLink
Log in

Prostaglandin I1 analogues, SM-10902 and SM-10906, affect human keratinocytes and fibroblasts in vitro in a manner similar to PGE1: therapeutic potential for wound healing

  • Original Paper
  • Published:
Archives of Dermatological Research Aims and scope Submit manuscript

Abstract

The newly synthesized prostaglandin (PG) I1 analogues, SM-10902 and SM-10906, were compared with PGE1 in terms of their biological effects on cultured normal human keratinocytes (NHKs) and human dermal fibroblasts (HDFs) in order to evaluate their therapeutic potential for cutaneous wound healing. The PGI1 analogues had a direct effect on cell proliferation of HDFs as did PGE1, but inibited cell growth of NHKs in contrast to the stimulatory effect observed with PGE1. In contrast to NHKs stimulated with PGI1 analogues, which exhibited low levels of adenosine 3,5-cyclic monophosphate (cAMP). HDFs stimulated with these analogues responded in a dose-dependent manner with extremely high levels of cAMP. Conditioned media (CM) derived from media in which HDFs had been incubated with both the PGI1 analogues promoted NHK proliferation. HDF production of interleukin (IL)-6 increased in response to the PGI1 analogues. Since IL-6 was shown to promote cell growth of NHKs, enhancement of NHK proliferation by CM was thought to be due to IL-6 derived from HDFs stimulated with the PGI1 analogues.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Ikai K, Ujihara M, Kashihara M, Fukushima M (1987) Inhibition of the proliferation of transformed epidermal cells in culture by various prostaglandins. J Invest Dermatol 89: 69–72

    Google Scholar 

  2. Zhang Y, Lin JX, Vilck J (1988) Synthesis of interleukin 6 (interferon-2/B cell stimulatory factor 2) in human fibroblasts is triggered by an increase in intracellular cyclic AMP. J Biol Chem 263: 6177–6182

    Google Scholar 

  3. Haynes DR, Whitehouse MW, Roberts V (1992) The prostaglandin E, analogue, Misoprostol, regulates inflammatory cytokines and immune functions in vitro like the natural prostaglandins E1, E2 and E3. Immunology 76: 251–257

    Google Scholar 

  4. Goldyne ME (1975) Prostaglandins and cutaneous inflammation. J Invest Dermatol 64: 377–385

    Google Scholar 

  5. Morisaki S (1993) Effect of topical application of prostaglandin E1 ointment on chronic skin ulcers and relation between tissue oxygen tension and its clinical efficacy (in Japanese). Skin Res 35: 210–218

    Google Scholar 

  6. Moncada S, Gryglewski RJ, Bunting S, Vane JR (1976) An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation. Nature 263: 663–665

    Google Scholar 

  7. Crane BH, Maish TL, Maddox YT, Corey EJ, Szekel I, Ramwell PW (1978) Effect of prostaglandin I2 and analogs on platelet aggregation and smooth muscle contraction. J Pharmacol Exp Ther 206: 132–138

    Google Scholar 

  8. Ivanics J, Simonidesz V, Galambos G, Kormoczy P, Kovacs G (1983) Synthesis of prostacyclin analogues via knoevenagel condensation. Tetrahedron Lett 24: 315–318

    Google Scholar 

  9. Zhang JZ, Maruyama K, Iwatsuki K, Ono I, Kaneko F (1994) Effects of prostaglandin E1 on human keratinocytes and dermal fibroblasts: a possible mechanism for the healing of skin ulcers. Exp Dermatol 3: 164–170

    Google Scholar 

  10. Kawakami H, Muraoka M, Sugie A, Ono K, Kojima A (1993) Synthesis of new 3-oxa-methano-PGI1 derivatives and their biological properties. Chem Lett 3: 2821–2826

    Google Scholar 

  11. Oka M, Negishi M, Satoh K, Yamamoto T, Hirohashi T, Ichikawa A (1994) Prostacyclin receptor binding and cAMP synthesis activities of PGI1 analogues, SM-10906 and its methyl ester, SM-10902, in mastocytoma P-815 cells. Biol Pharm Bull 17: 74–77

    Google Scholar 

  12. Yamamoto T, Satoh K, Nishimura T, Horikawa N, Mine T, Hirohashi T, Hara Y (1994) Pharmacological properties of the new stable prostacyclin analogue 3-oxamethano-prostaglandin I1. Arzneimittelforschung 44: 483–490

    Google Scholar 

  13. Zhang JZ, Maruyama K, Ono I, Kaneko F (1994) Regulatory effects of 1,25-dihydroxyvitamin D3 and a novel vitamin D3 analogue MC903 on the production of interleukin-1 alpha (IL- 1α) and IL-8 by normal human keratinocytes and a squamous cell carcinoma cell line (HSC-1). J Dermatol Sci 7: 24–31

    Google Scholar 

  14. Maruyama K, Zhang JZ, Nihei Y, Ono I, Kaneko F (1995) Regulatory effects of antipsoriatic agents on interleukin-1 production by human keratinocytes stimulated with gamma-interferon in vitro. Skin Pharmacol (in press)

  15. Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Med 65: 55–63

    Google Scholar 

  16. Lowry OH, Rosenbrough NJ, Lewis FA, Randal RJ (1951) Protein measurement with the folin phenol reagent. J Biol Chem 193: 265–275

    Google Scholar 

  17. Quadrons E, Ramsamooj MS, Wilson DE (1987) Role of mucus and prostaglandins in the gastric mucosal protective actions of sucralfate against ethanol-induced injury in rats. J Med 83 [Suppl 3B]: 19–23

    Google Scholar 

  18. Burch RM, McMillan BA (1991) Sucralfate induces proliferation of dermal fibroblasts and keratinocytes in culture and granulation tissue formation in full thickness skin wounds. Agents Actions 34: 229–231

    Google Scholar 

  19. Pentland AP, George J, Moran C, Needleman P (1987) Cellular confluence determines injury-induced prostaglandin E2 synthesis by human keratinocyte cultures. Biochim Biophys Acta 919: 71–78

    Google Scholar 

  20. Shirakawa J, Horikawa Y, Yaku H, Takeshi M, Obara H (1992) Combined therapy with prostaglandin E1 ointment and lumbar sympathetic ganglion block on intractable skin ulcers accompanied by Burger's disease. Anesthesiol (Japanese) 41: 1000–1003

    Google Scholar 

  21. Shibasaki M, Iseki K, Ikegami S (1980) Total synthesis of the analog of Δ6-PGI1. Tetrahedron Lett 21: 169–172

    Google Scholar 

  22. Yatsunami K, Ichikawa A, Tomita K (1981) Accumulation of adenosine 3,5-monophosphate induced by prostaglandin E1 binding to mastocytoma P-815 cells. Biochem Pharmacol 30: 1325–1332

    Google Scholar 

  23. Clark RAF (1985) Cutaneous tissue repair: basic biology considerations I. J Am Acad Dermatol 13: 701–725

    Google Scholar 

  24. Seghal PB (1990) Interkeukin-6: molecular pathophysiology. J Invest Dermatol 94: 2S-6S

    Google Scholar 

  25. Boxman I, Lowik C, Aarden L, Ponec M (1993) Modulation of IL-6 production and IL-1 activity by keratinocyte-fibroblast interaction. J Invest Dermatol 101: 316–324

    Google Scholar 

  26. Grossman RM, Kreuger J, Yourish D, Granelli-Peperno A, Murphy DP, May LT, Kupper TS, Sehgar J, Gottlieb AB (1989) Interleukin-6 is expressed in high levels in psoriasis skin and stimulates proliferation of cultured human keratinocytes. Proc Natl Acad Sci USA 86: 6367–6371

    Google Scholar 

  27. Dutta-Roy AK, Sinha AK 81987) Purification and properties of prostaglandin E1/prostacyclin receptor of human blood platelets. J Biol Chem 262: 12685–12691

    Google Scholar 

  28. Kuroki T, Ito T, Hosomo J, Munakata K, Uchida T, Nagai Y (1982) Cyclic AMP as a mitotic signal for epidermal keratinocytes, but not for dermal fibroblasts. Cell Struct Funct 7: 295–305

    Google Scholar 

  29. Falanga V, Katz MH, Alvarez A (1991) Dibutyryl cyclic AMP by itself or in combination with growth factor can stimulate or inhibit growth of human keratinocytes and dermal fibroblasts. Wounds 3: 70–78

    Google Scholar 

  30. Marcinkiewicz J (1991) In vitro cytokine release by activated murine peritoneal macrophages: role of prostaglandins in the differential regulation of tumor necrosis factor alpha, interleukin 1 and interleukin 6. Cytokines 3: 327–332

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Dermatology, Fukushima Medical College, Hikarigaoka 1, 960-12, Fukushima, Japan

    F. Kaneko, J. -Z. Zhang, K. Maruyama, Y. Nihei, I. Ono & K. Iwatsuki

  2. Rearch Center, Sumitomo Pharmaceuticals Co. Ltd., HinodeNaka, 3-1-98, Konohanaku, 554, Osaka, Japan

    T. Yamamoto

Authors
  1. F. Kaneko
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. -Z. Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. K. Maruyama
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Y. Nihei
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. I. Ono
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. K. Iwatsuki
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. T. Yamamoto
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kaneko, F., Zhang, J.Z., Maruyama, K. et al. Prostaglandin I1 analogues, SM-10902 and SM-10906, affect human keratinocytes and fibroblasts in vitro in a manner similar to PGE1: therapeutic potential for wound healing. Arch Dermatol Res 287, 539–545 (1995). https://doi.org/10.1007/BF00374073

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00374073

Key words

Search

Navigation